Patricia M. Wagner

Patricia M. Wagner
Epstein Becker & Green, P.C.
Member
202-861-4182
Website
www.ebglaw.com/patricia-m-wagner/
Organization Profile Full Profile
Connect
- Email

Professional Biography:

PATRICIA M. WAGNER is a Member of the Firm in the Health Care and Life Sciences and Litigation practices, in the firm's Washington, DC, office. In 2014, Ms. Wagner was selected to the Washington DC Super Lawyers list in the area of Health Care.

Ms. Wagner's experience includes the following:

Advising clients on a variety of matters related to federal and state antitrust issues

Representing clients in antitrust matters in front of the Federal Trade Commission and the United States Department of Justice, and state antitrust authorities

Advising clients on issues related HIPAA Privacy and security

Advising clients on issues related to state licensure and regulatory requirements

Articles in the National Law Review database by Patricia M. Wagner

DOJ’s Antitrust Division Continues Its Pursuit of Overlapping Directorates (Posted On Thursday, March 16, 2023)
Accompanying Statements to Hart-Scott-Rodino Annual Report Exemplify Ongoing Tension at FTC (Posted On Thursday, February 23, 2023)
DOJ Withdraws Long-Standing Support for Antitrust Enforcement Policy Statements in Health Care (Posted On Wednesday, February 8, 2023)
DOJ Withdraws Long-Standing Health Care Antitrust Enforcement Policy Statements (Posted On Monday, February 6, 2023)
HHS Warns HIPAA Covered Entities and Business Associates That Use of Website Cookies, Pixels, and Other Tracking Technology May Violate HIPAA Rules (Posted On Tuesday, December 27, 2022)
DOJ and HHS Coordinate Enforcement Efforts in Health Care (Posted On Thursday, December 22, 2022)
DOJ Continues to Emphasize Antitrust Merger Enforcement (Posted On Thursday, December 8, 2022)
HHS Warns HIPAA Covered Entities and Business Associates That Use of Website Cookies, Pixels and Other Tracking Technology May Violate HIPAA Rules (Posted On Monday, December 5, 2022)
FTC Tries Again to Provide Guidance on Enforcement Under Section 5 of FTC Act (Posted On Thursday, November 17, 2022)
Independent Physician Association Enforcement Not Forgotten (Posted On Friday, November 4, 2022)
FTC Commissioner Favors Fairness over Efficiency (Posted On Thursday, October 13, 2022)
FTC Testimony to Senate—with a Dissent (Posted On Thursday, September 29, 2022)
FTC Publishes Its Strategic Plan for Next Five Years (Posted On Thursday, September 15, 2022)
FTC Maintains Strong Opposition to COPAs (Posted On Thursday, August 25, 2022)
FTC Reaches Agreement with NLRB to Further Protect Labor Markets (Posted On Thursday, August 11, 2022)
On First Anniversary of Executive Order on Competition, DOJ Celebrates Interagency Efforts to Promote Competitive Markets (Posted On Thursday, July 28, 2022)
Recent Actions Highlight That Price Fixing Reaches Beyond Agreements on the Ultimate Price (Posted On Thursday, July 14, 2022)
Federal Trade Commission’s Focus on Pharmacy Benefit Managers (Posted On Thursday, June 23, 2022)
A Recently-Released “Discussion Draft” of the “American Data Privacy and Protection Act” Provides Insight into Recent Bipartisan Efforts to Pass Nationwide Privacy Law (Posted On Thursday, June 9, 2022)
Constitutionality of FTC’s Structure and Procedures Under SCOTUS Review (Posted On Thursday, June 9, 2022)

Pages

FTC Regulation

FTC Coverage and Updates

The National Law Review awards Epstein Becker & Green attorneys E. John Steren and Patricia M. Wagner with a Go-To Thought Leadership award for their coverage of a range of competition law topics including personnel changes at the FTC and the large uptick in Hart-Scott-Rodino (“HSR”) filings the FTC received in 2021. Exceptionally helpful to the NLR's readers in 2021 were Mr. Steren's & Ms. Wagner's actionable insights on how the new direction at the FTC impacts the pharmaceutical and healthcare industries.